Wealthstream Advisors, Inc. Dr Reddys Laboratories LTD Transaction History
Wealthstream Advisors, Inc.
- $519 Million
- Q4 2024
A detailed history of Wealthstream Advisors, Inc. transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Wealthstream Advisors, Inc. holds 14,546 shares of RDY stock, worth $200,880. This represents 0.04% of its overall portfolio holdings.
Number of Shares
14,546
Previous 2,758
427.41%
Holding current value
$200,880
Previous $219,000
4.57%
% of portfolio
0.04%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding RDY
# of Institutions
257Shares Held
39.8MCall Options Held
12.7KPut Options Held
6.1K-
Robeco Institutional Asset Management B.V.11.4MShares$158 Million0.35% of portfolio
-
Aikya Investment Management LTD London, X05.61MShares$77.5 Million36.88% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.9MShares$67.6 Million0.0% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa2.47MShares$34.1 Million0.02% of portfolio
-
Morgan Stanley New York, NY2.24MShares$31 Million0.01% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.29B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...